Disposition of a synthetic analogue of lipid A (E5564) in rats

References

• ACTON, S., RIGOTTI, A., LANDSCHULZ, K. T., Xu, S., HOBBS, H. H. and KRIEGER, M., 1996, Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science, 271, 518–520.
   PubMed Web of Science ®Google Scholar
• BLIGH, E. G. and DYER, W. J., 1959, A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology, 37, 911–917.
   PubMedGoogle Scholar
• DAVIES, B. and MORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmaceutical Research, 10, 1093–1095.
   PubMed Web of Science ®Google Scholar
• GLAUSER, M. P., ZANETTI, G., BAUMGARTNER, J. D. and COHEN, J., 1991, Septic shock: patho-genesis. Lancet, 338, 732–736.
   PubMed Web of Science ®Google Scholar
• HAMPTON, R. Y. and RAETZ, C. R., 1991, Macrophage catabolism of lipid A is regulated by endotoxin stimulation. Journal of Biological Chemistry, 266, 19499–19509.
   PubMed Web of Science ®Google Scholar
• HARRIS, H. W., GRUNFELD, C., FEINGOLD, K. R., READ, T. E., KANE, J. P., JONES, A. L., EICHBAUM, E. B., BLAND, G. F. and RAPP, J. H., 1993, Chylomicrons alter the fate of endotoxin, decreasing tumour necrosis factor release and preventing death. Journal of Clinical Investigation, 91, 1028–1034.
   PubMed Web of Science ®Google Scholar
• KANEKO, K., UEDA, R., KIKUCHI, K., SANO, Y. and YOSHIMURA, T., 1999, Quantitative determination of a potent lipopolysaccharide antagonist, E5564, in rat and dog plasma by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B: Biomedical and Science Applications, 736, 67–75.
   PubMed Web of Science ®Google Scholar
• LIEN, E., CHOW, J. C., HAWKINS, L. D., MCGUINNESS, P. D., MIYAKE, K., ESPEVIK, T., GUSOVSKY, F. and GOLENBOCK, D. T., 2001, A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway. Journal of Biological Chemistry, 276, 1873–1880.
   PubMed Web of Science ®Google Scholar
• LOPPNOW, H., BRADE, H., DURRBAUM, I., DINARELLO, C. A., KUSUMOTO, S., RIETSCHEL, E. T. and FLAD, H. D., 1989, IL-1 induction-capacity of defined lipopolysaccharide partial structures. Journal of Immunology, 142, 3299–3238.
   Web of Science ®Google Scholar
• LOPPNOW, H., LIBBY, P., FREUDENBERG, M., KRAUSS, J. H., WECKESSER, J. and MAYER, H., 1990, Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infections and Immunology, 58, 3743–3750.
   PubMed Web of Science ®Google Scholar
• MATHISON, J. C. and ULEVITCH, R. J., 1979, The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. Journal of Immunology, 123, 2133–2143.
   PubMed Web of Science ®Google Scholar
• MATHISON, J. C. and ULEVITCH, R. J., 1985, Uptake and subcellular localization of bacterial lipopolysaccharide in the adrenal gland. American Journal of Pathology, 120, 79–86.
   PubMed Web of Science ®Google Scholar
• MORRISON, D. C., DANNER, R. L., DINARELLO, C. A., MUNFORD, R. S., NATANSON, C., POLLACK, M., SPITZER, J. J., ULEVITCH, R. J., VOGEL, S. N. and MCSWEEGAN, E., 1994, Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction. Journal of Endotoxin Research, 1, 71–83.
   Google Scholar
• MUNFORD, R. S. and DIETSCHY, J. M., 1985, Effects of specific antibodies, hormones, and lipoproteins on bacterial lipopolysaccharides injected into the rat. Journal of Infectious Diseases, 152, 177–184.
   PubMed Web of Science ®Google Scholar
• PETERSON, A. A. and MUNFORD, R. S., 1987, Dephosphorylation of the lipid A moiety of Escherichia coli lipopolysaccharide by mouse macrophages. Infection and Immunology, 55, 974–978.
   PubMed Web of Science ®Google Scholar
• RAETZ, C. R., 1990, Biochemistry of endotoxins. Annual Review of Biochemistry, 59, 129–170.
   PubMed Web of Science ®Google Scholar
• RIETSCHEL, E. T., KIRIKAE, T., SCHADE, F., MAMAT, U., SCHMIDT, G., LOPPNOW, H., ULMER, A. J., ZAHRINGER, U., SEYDEL, U., DI PADOVA, F., SCHREIER, M. and BRADE, H., 1994, Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB Journal, 8, 217–225.
   PubMed Web of Science ®Google Scholar
• ROSSIGNOL, D. P., HAWKINS, L. D., CHRIST, W. J., KOBAYASHI, S., KAWATA, T., LYNN, M., YAMATSU, I. and Klan, Y., 1999, Synthetic endotoxin antagonists. In: H. Brade, S. M. Opal, S. N. Vogel and D. C. Morrison (eds), Endotoxin in Health and Disease (New York: Marcel Dekker), pp. 699–717.
   Google Scholar
• SCHLETTER, J., HEINE, H., ULMER, A. J. and RIETSCHEL, E. T., 1995, Molecular mechanisms of endotoxin activity. Archives in Microbiology, 164, 383–389.
   PubMed Web of Science ®Google Scholar
• TAKAYAMA, K., QURESHI, N., BEUTLER, B. and KIRKLAND, T. N., 1989, Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infections and Immunology, 57, 1336–1338.
   PubMed Web of Science ®Google Scholar
• ULEVITCH, R. J., JOHNSTON, A. R. and WEINSTEIN, D. B., 1979, New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. Journal of Clinical Investigation, 64, 1516–1524.
   PubMed Web of Science ®Google Scholar
• WURFEL, M. M., HAILMAN, E. and WRIGHT, S. D., 1995, Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. Journal of Experimental Medicine, 181, 1743–1754.
   PubMed Web of Science ®Google Scholar
• ZAHRINGER, U., LINDNER, B. and RIETSCHEL, E. T., 1994, Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Advances in Carbohydrate Chemistry and Biochemistry, 50, 211–276.
   PubMed Web of Science ®Google Scholar
• ZAHRINGER, U., LINDNER, B. and RIETSCHEL, E. T., 1999, Chemical structure of lipid A: recent advances in structural analysis of biologically active molecules. In: H. Brade, S. M. Opal, S. N. Vogel and D. C. Morrison (eds), Endotoxin in Health and Disease (New York: Marcel Dekker), pp. 93–114.
   Google Scholar